Conjunctivitis Market by Type, Treatment & Region | Forecast 2022 to 2032

<p>The global <strong>conjunctivitis market </strong>size is expected to be worth US$ 1,825.8 Million in 2022. The market is expected to reach US$ 3,208.7 Million by 2032, growing at a 5.8% CAGR from 2022 to 2032.</p><table><tbody><tr><th scope='row'>Report Attribute</th><td>Details</td></tr><tr><th scope='row'>Conjunctivitis Market Value (2022)</th><td>US$ 1825.8 Million</td></tr><tr><th scope='row'>Conjunctivitis Market Anticipated Value (2032)</th><td>US$ 3208.7 Million</td></tr><tr><th scope='row'>Conjunctivitis Projected Growth Rate (2022 to 2032)</th><td>5.8%</td></tr></tbody></table><p>Report Scope</p><table><tbody><tr><th scope='row'>Report Attribute</th><td>Details</td></tr><tr><th scope='row'>Growth Rate</th><td>CAGR of 5.8% from 2022 to 2032</td></tr><tr><th scope='row'>Base Year for Estimation</th><td>2021</td></tr><tr><th scope='row'>Historical Data</th><td>2016 to 2021</td></tr><tr><th scope='row'>Forecast Period</th><td>2022 to 2032</td></tr><tr><th scope='row'>Quantitative Units</th><td>Revenue in US$ Million and CAGR from 2022 to 2032</td></tr><tr><th scope='row'>Report Coverage</th><td>Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis</td></tr><tr><th scope='row'>Segments Covered</th><td><ul><li>Type</li><li>Treatment</li><li>Region</li></ul></td></tr><tr><th scope='row'>Regions Covered</th><td><ul><li>North America</li><li>Latin America</li><li>Europe</li><li>East Asia</li><li>South Asia</li><li>Oceania</li><li>Middle East and Africa</li></ul></td></tr><tr><th scope='row'>Key Countries Profiled</th><td><ul><li>United States of America</li><li>Canada</li><li>Brazil</li><li>Argentina</li><li>Germany</li><li>United Kingdom</li><li>France</li><li>Spain</li><li>Italy</li><li>Nordics</li><li>BENELUX</li><li>Australia &amp; New Zealand</li><li>China</li><li>India</li><li>ASIAN</li><li>GCC Countries</li><li>South Africa</li></ul></td></tr><tr><th scope='row'>Key Companies Profiled</th><td><ul><li>Boehringer Ingelheim GmbH</li><li>Allergan Inc.</li><li>Sanofi-Aventis</li><li>Atopix Therapeutics Ltd.</li><li>Novartis AG,&nbsp;Ocular Therapeutix&nbsp;Inc.</li><li>Bausch &amp; Lomb Inc.</li><li>Akorn Incorporated.</li><li>Auven Therapeutics</li><li>Sirion Therapeutics&nbsp;Inc.</li><li>Sun Pharma Advanced Research Company Ltd.</li><li>Boehringer Ingelheim International GmbH.</li><li>IBA Vision Ophthalmics</li><li>Pfizer Inc.</li><li>Merck &amp; Co.&nbsp;Inc.</li><li>Santen Pharmaceuticals Co. Ltd.</li></ul></td></tr><tr><th scope='row'>Customization</th><td>Available Upon Request</td></tr></tbody></table>

<p>全球结膜炎市场规模预计于2022年达到18.26亿美元。预计到2032年，市场规模将达到32.09亿美元，从2022年至2032年以5.8%的复合年增长率持续增长。</p><table><tbody><tr><th scope='row'>报告属性</th><td>详细信息</td></tr><tr><th scope='row'>结膜炎市场规模（2022年）</th><td>18.26亿美元</td></tr><tr><th scope='row'>结膜炎市场预计价值（2032年）</th><td>32.09亿美元</td></tr><tr><th scope='row'>结膜炎预测增长率（2022年至2032年）</th><td>5.8%</td></tr></tbody></table><p>报告范围</p><table><tbody><tr><th scope='row'>报告属性</th><td>详细信息</td></tr><tr><th scope='row'>增长率</th><td>2022年至2032年的复合年增长率为5.8%</td></tr><tr><th scope='row'>估算基准年</th><td>2021年</td></tr><tr><th scope='row'>历史数据</th><td>2016年至2021年</td></tr><tr><th scope='row'>预测期</th><td>2022年至2032年</td></tr><tr><th scope='row'>量化单位</th><td>以亿美元计的收入和2022年至2032年的复合年增长率</td></tr><tr><th scope='row'>报告覆盖范围</th><td>收入预测、数量预测、公司排名、竞争格局、增长因素、趋势和定价分析</td></tr><tr><th scope='row'>涵盖的细分市场</th><td><ul><li>类型</li><li>治疗</li><li>地区</li></ul></td></tr><tr><th scope='row'>涵盖的地区</th><td><ul><li>北美</li><li>拉丁美洲</li><li>欧洲</li><li>东亚</li><li>南亚</li><li>大洋洲</li><li>中东和非洲</li></ul></td></tr><tr><th scope='row'>概述的关键国家</th><td><ul><li>美国</li><li>加拿大</li><li>巴西</li><li>阿根廷</li><li>德国</li><li>英国</li><li>法国</li><li>西班牙</li><li>意大利</li><li>北欧</li><li>比荷卢</li><li>澳大利亚及新西兰</li><li>中国</li><li>印度</li><li>亚洲</li><li>海湾合作委员会国家</li><li>南非</li></ul></td></tr><tr><th scope='row'>概述的关键公司</th><td><ul><li>Boehringer Ingelheim GmbH</li><li>Allergan Inc.</li><li>Sanofi-Aventis</li><li>Atopix Therapeutics Ltd.</li><li>Novartis AG, Ocular Therapeutix Inc.</li><li>Bausch & Lomb Inc.</li><li>Akorn Incorporated.</li><li>Auven Therapeutics</li><li>Sirion Therapeutics Inc.</li><li>Sun Pharma Advanced Research Company Ltd.</li><li>Boehringer Ingelheim International GmbH.</li><li>IBA Vision Ophthalmics</li><li>Pfizer Inc.</li><li>Merck & Co. Inc.</li><li>Santen Pharmaceuticals Co. Ltd.</li></ul></td></tr><tr><th scope='row'>定制服务</th><td>根据需求提供</td></tr></tbody></table>